Scholars Central

Conference abstractPublished 2016

Genetic markers that predict sensitivity of tumor cells to infection by Sendai virus

Authors: Anastasia O. Sosnovtseva, Dmitriy V. Kochetkov, Anastasia V. Lipatova, Darya A. Berzhitskaya, Andrey O. Zheltukhin

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Oncolytic virotherapy is a new promising approach to treatment of various oncological diseases. At present Sendai Virus (SeV) is being actively investigated as a promising oncolytic drug. A number of studies have shown that recombinant and UV inactivated SeV is capable of effective elimination of tumor cells while sparing normal cells. SeV eradicates tumor cells mostly via induction of apoptosis, autophagy and necroptosis and, also, by induction of antitumor immunity. In this study we have demonstrated that primary lines derived from adenocarcinoma of prostate exhibit a differential sensitivity to SeV. ItâÂ?Â?s necessary to uncover genetic markers of interaction between malignant cells and viruses to enable a personalized approach to treatment and increase effectiveness of virotherapy. Quantitative PCR was used to estimate levels of expression of genes encoding RIG-1 like and Toll like receptors (TLR). It was demonstrated that levels of expression of TLR3 and TLR7 correlated with the degree of sensitivity of tumor cells from prostate gland to Sendai virus in a statistically significant way. Cell lines with the least expression of TLR3 and TLR7 exhibit the highest degree of sensitivity to that virus. A more detailed investigation of the mechanism of action of that viral strain will allow to uncover additional markers that would enable prediction of sensitivity of tumors from a particular patient to SeV and effectiveness of the oncolytic drug in the therapeutic regimen used with an utmost accuracy. Acknowledgements: our research was supported by Russian Ministry of Education grant RFMEFI60714X0067

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Oncology & Cancer Case Reports.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalOncology & Cancer Case Reports
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Anastasia O. Sosnovtseva”
  • BylineArticles whose byline prints “Dmitriy V. Kochetkov”
  • BylineArticles whose byline prints “Anastasia V. Lipatova”
  • BylineArticles whose byline prints “Darya A. Berzhitskaya”
  • BylineArticles whose byline prints “Andrey O. Zheltukhin”